| Molecular Dynamics of HIV (R01 Clinical Trial Not Allowed)- RFA-AI-22-050 |
R01
|
June 27, 2022 |
December 08, 2022 |
| Limited Competition—A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research (U24 Clinical Trial Not Allowed)- RFA-CA-22-026 |
U24
|
June 14, 2022 |
September 16, 2022 |
| Research Coordinating Center to Support Climate Change and Health Community of Practice (U24 Clinical Trial Not Allowed)- RFA-ES-22-003 |
U24
|
June 06, 2022 |
August 26, 2022 |
| Data Management Coordinating Center for Diagnostic Centers of Excellence (U2C Clinical Trial Not Allowed) - RFA-NS-22-051 |
U2C
|
June 06, 2022 |
August 11, 2022 |
| Notice of Special Interest (NOSI)— Innovative Technologies for Research on Climate Change and Human Health Small Business Technology Transfer (R41/R42 Clinical Trial Optional)- NOT-ES-22-009 |
R41/R42
|
June 03, 2022 |
April 06, 2023 |
| Notice of Special Interest (NOSI)—Innovative Technologies for Research on Climate Change and Human Health Small Business Innovation Research (R43/R44 Clinical Trial Optional)- NOT-ES-22-010 |
R43/R44
|
June 03, 2022 |
April 06, 2023 |
| PHS 2022-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)- PA-22-176 |
R43/R44
|
June 02, 2022 |
April 06, 2023 |
| PHS 2022-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)- PA-22-178 |
R41/R42
|
June 02, 2022 |
April 06, 2023 |
| Notice of Special Interest (NOSI)— Climate Change and Health- NOT-ES-22-006 |
Multiple |
June 01, 2022 |
May 08, 2025 |
| Resources Access for Preclinical Integrated Drug Development (RAPIDD) Program (X01 Clinical Trial Not Allowed)- PAR-22-185 |
X01
|
May 27, 2022 |
January 18, 2025 |
| A Multi-omics Approach to Immune Responses in HIV Vaccination and Intervention (P01 Clinical Trial Not Allowed)- RFA-AI-22-038 |
P01
|
May 27, 2022 |
October 14, 2022 |
| Notice of Special Interest—Administrative Supplements to Advance Precision Medicine Using the All of Us Research Programs Data- NOT-PM-22-002 |
Supp
|
May 20, 2022 |
July 06, 2022 |
| Transgender People—Immunity, Prevention, and Treatment of HIV and STIs (R21 Clinical Trial Not Allowed)- PAR-22-186 |
R21
|
May 19, 2022 |
December 08, 2024 |
| Understanding the Clinical History of Bacterial Sexually Transmitted Infections (STI) to Accelerate Diagnostic and Vaccine Development (R01 Clinical Trial Not Allowed)- RFA-AI-22-034 |
R01
|
May 12, 2022 |
September 13, 2022 |
| Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)- PAR-22-105 |
R01
|
May 10, 2022 |
May 08, 2025 |
| Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)- PAR-22-109 |
R21
|
May 10, 2022 |
May 08, 2025 |
| Partnerships for Development of Vaccines Against Select Enteric Pathogens (R01 Clinical Trial Not Allowed)- RFA-AI-22-037 |
R01
|
May 10, 2022 |
September 15, 2022 |
| Understanding the Basic Mechanisms of Immune-related Adverse Events (irAEs) in Cancer Immunotherapy- NOT-CA-22-063 |
Multiple |
May 03, 2022 |
July 05, 2024 |
| Notice of Special Interest (NOSI)— Sustained Release of Antivirals for Treatment or Prevention of HIV or Treatment of Latent TB/HBV (SRATP) - NOT-AI-22-042 |
R01
|
April 29, 2022 |
May 08, 2025 |
| Notice of Special Interest (NOSI)—Towards Developing a Cure for HBV in HIV/HBV Co-Infection - NOT-AI-22-043 |
R01, R41/R42, R21, R43/R44
|
April 29, 2022 |
May 08, 2025 |
| Limited Interaction Targeted Epidemiology—Viral Suppression (LITE-VS) (UG3/UH3 Clinical Trial Optional)- RFA-AI-22-024 |
UG3/UH3
|
April 13, 2022 |
August 04, 2022 |
| Small Research Grants for Analysis, Curation, and/or Sharing of Down syndrome-related Research Data for the INCLUDE Project (R03 Clinical Trial Not Allowed)- RFA-OD-22-008 |
R03
|
April 08, 2022 |
July 02, 2024 |
| Notice of Special Interest (NOSI)—Administrative Supplements for Research on Womens Health in the IDeA States- NOT-GM-22-005 |
Supp
|
April 06, 2022 |
October 18, 2024 |
| Development and Optimization of Next-Generation Immunological Assays to Support Influenza Clinical Studies and Trials (UH2/UH3 Clinical Trial Not Allowed)- RFA-AI-22-020 |
UH2/UH3
|
April 05, 2022 |
July 02, 2022 |
| Partnerships for the Development of Novel Therapeutics to Combat Select Antibiotic Resistant Bacteria and Fungi (R01 Clinical Trial Not Allowed)- RFA-AI-22-028 |
R01
|
April 05, 2022 |
July 30, 2022 |
